Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,843
archived clinical trials in
Colorectal Cancer

Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease: OCEANIA Study
Status: Enrolling
Updated:  2/16/2017
MGG Group, Co. Inc./Chevy Chase Clinical Research
mi
from
Chevy Chase, MD
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease: OCEANIA Study
Status: Enrolling
Updated: 2/16/2017
MGG Group, Co. Inc./Chevy Chase Clinical Research
mi
from
Chevy Chase, MD
Click here to add this to my saved trials
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease: OCEANIA Study
Status: Enrolling
Updated:  2/16/2017
Massachusetts General Hospital
mi
from
Boston, MA
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease: OCEANIA Study
Status: Enrolling
Updated: 2/16/2017
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease: OCEANIA Study
Status: Enrolling
Updated:  2/16/2017
Boston Med Ctr
mi
from
Boston, MA
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease: OCEANIA Study
Status: Enrolling
Updated: 2/16/2017
Boston Med Ctr
mi
from
Boston, MA
Click here to add this to my saved trials
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease: OCEANIA Study
Status: Enrolling
Updated:  2/16/2017
Detroit Clinical Research Center PC
mi
from
Farmington Hills, MI
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease: OCEANIA Study
Status: Enrolling
Updated: 2/16/2017
Detroit Clinical Research Center PC
mi
from
Farmington Hills, MI
Click here to add this to my saved trials
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease: OCEANIA Study
Status: Enrolling
Updated:  2/16/2017
The Mayo Clinic
mi
from
Rochester, MN
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease: OCEANIA Study
Status: Enrolling
Updated: 2/16/2017
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease: OCEANIA Study
Status: Enrolling
Updated:  2/16/2017
Center for Digestive & Liver Diseases Inc.
mi
from
Mexico, MO
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease: OCEANIA Study
Status: Enrolling
Updated: 2/16/2017
Center for Digestive & Liver Diseases Inc.
mi
from
Mexico, MO
Click here to add this to my saved trials
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease: OCEANIA Study
Status: Enrolling
Updated:  2/16/2017
Medical Research Associates of New York
mi
from
New York, NY
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease: OCEANIA Study
Status: Enrolling
Updated: 2/16/2017
Medical Research Associates of New York
mi
from
New York, NY
Click here to add this to my saved trials
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease: OCEANIA Study
Status: Enrolling
Updated:  2/16/2017
Asheville Gastroeneterology Associates
mi
from
Asheville, NC
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease: OCEANIA Study
Status: Enrolling
Updated: 2/16/2017
Asheville Gastroeneterology Associates
mi
from
Asheville, NC
Click here to add this to my saved trials
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease: OCEANIA Study
Status: Enrolling
Updated:  2/16/2017
Univeristy of North Carolina
mi
from
Chapel Hill, NC
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease: OCEANIA Study
Status: Enrolling
Updated: 2/16/2017
Univeristy of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease: OCEANIA Study
Status: Enrolling
Updated:  2/16/2017
Cleveland Clinic
mi
from
Cleveland, OH
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease: OCEANIA Study
Status: Enrolling
Updated: 2/16/2017
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease: OCEANIA Study
Status: Enrolling
Updated:  2/16/2017
Vanderbilt University Medical Center
mi
from
Nashville, TN
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease: OCEANIA Study
Status: Enrolling
Updated: 2/16/2017
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease: OCEANIA Study
Status: Enrolling
Updated:  2/16/2017
Houston Methodist Hospital
mi
from
Houston, TX
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease: OCEANIA Study
Status: Enrolling
Updated: 2/16/2017
Houston Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease: OCEANIA Study
Status: Enrolling
Updated:  2/16/2017
Advanced Research Institute
mi
from
Logan, UT
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease: OCEANIA Study
Status: Enrolling
Updated: 2/16/2017
Advanced Research Institute
mi
from
Logan, UT
Click here to add this to my saved trials
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease: OCEANIA Study
Status: Enrolling
Updated:  2/16/2017
Blue Ridge Medical Research
mi
from
Lynchburg, VA
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease: OCEANIA Study
Status: Enrolling
Updated: 2/16/2017
Blue Ridge Medical Research
mi
from
Lynchburg, VA
Click here to add this to my saved trials
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease: OCEANIA Study
Status: Enrolling
Updated:  2/16/2017
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease: OCEANIA Study
Status: Enrolling
Updated: 2/16/2017
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Click here to add this to my saved trials
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease: OCEANIA Study
Status: Enrolling
Updated:  2/16/2017
Wisconsin Center for Advanced Research
mi
from
Milwaukee, WI
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease: OCEANIA Study
Status: Enrolling
Updated: 2/16/2017
Wisconsin Center for Advanced Research
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease: OCEANIA Study
Status: Enrolling
Updated:  2/16/2017
Mount Sinai School of Medicine
mi
from
New York, NY
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease: OCEANIA Study
Status: Enrolling
Updated: 2/16/2017
Mount Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease: OCEANIA Study
Status: Enrolling
Updated:  2/16/2017
University of Calgary
mi
from
Calgary,
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease: OCEANIA Study
Status: Enrolling
Updated: 2/16/2017
University of Calgary
mi
from
Calgary,
Click here to add this to my saved trials
SU011248 in Combination With Irinotecan and Cetuximab as a Second Line Regimen for Stage IV Colorectal Cancer
A Phase I/II Study of SU011248 (Sutent) in Combination With Irinotecan and Cetuximab as a Second Line Regimen for Patients With Stage IV Colorectal Cancer
Status: Enrolling
Updated:  2/16/2017
Massachusetts General Hospital
mi
from
Boston, MA
SU011248 in Combination With Irinotecan and Cetuximab as a Second Line Regimen for Stage IV Colorectal Cancer
A Phase I/II Study of SU011248 (Sutent) in Combination With Irinotecan and Cetuximab as a Second Line Regimen for Patients With Stage IV Colorectal Cancer
Status: Enrolling
Updated: 2/16/2017
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
SU011248 in Combination With Irinotecan and Cetuximab as a Second Line Regimen for Stage IV Colorectal Cancer
A Phase I/II Study of SU011248 (Sutent) in Combination With Irinotecan and Cetuximab as a Second Line Regimen for Patients With Stage IV Colorectal Cancer
Status: Enrolling
Updated:  2/16/2017
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
SU011248 in Combination With Irinotecan and Cetuximab as a Second Line Regimen for Stage IV Colorectal Cancer
A Phase I/II Study of SU011248 (Sutent) in Combination With Irinotecan and Cetuximab as a Second Line Regimen for Patients With Stage IV Colorectal Cancer
Status: Enrolling
Updated: 2/16/2017
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
SU011248 in Combination With Irinotecan and Cetuximab as a Second Line Regimen for Stage IV Colorectal Cancer
A Phase I/II Study of SU011248 (Sutent) in Combination With Irinotecan and Cetuximab as a Second Line Regimen for Patients With Stage IV Colorectal Cancer
Status: Enrolling
Updated:  2/16/2017
Dana-Farber Cancer Institute
mi
from
Boston, MA
SU011248 in Combination With Irinotecan and Cetuximab as a Second Line Regimen for Stage IV Colorectal Cancer
A Phase I/II Study of SU011248 (Sutent) in Combination With Irinotecan and Cetuximab as a Second Line Regimen for Patients With Stage IV Colorectal Cancer
Status: Enrolling
Updated: 2/16/2017
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
A Multicenter, Single Arm, Open Label Clinical Trial to Evaluate the Safety and Health-Related Quality of Life of Aflibercept in Patients With Metastatic Colorectal Cancer (mCRC) Previously Treated With an Oxaliplatin-Containing Regimen
Status: Enrolling
Updated:  2/28/2017
Clinical Research Facility
mi
from
Muscle Shoals, AL
Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
A Multicenter, Single Arm, Open Label Clinical Trial to Evaluate the Safety and Health-Related Quality of Life of Aflibercept in Patients With Metastatic Colorectal Cancer (mCRC) Previously Treated With an Oxaliplatin-Containing Regimen
Status: Enrolling
Updated: 2/28/2017
Clinical Research Facility
mi
from
Muscle Shoals, AL
Click here to add this to my saved trials
Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
A Multicenter, Single Arm, Open Label Clinical Trial to Evaluate the Safety and Health-Related Quality of Life of Aflibercept in Patients With Metastatic Colorectal Cancer (mCRC) Previously Treated With an Oxaliplatin-Containing Regimen
Status: Enrolling
Updated:  2/28/2017
Clinical Research Facility
mi
from
Corona, CA
Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
A Multicenter, Single Arm, Open Label Clinical Trial to Evaluate the Safety and Health-Related Quality of Life of Aflibercept in Patients With Metastatic Colorectal Cancer (mCRC) Previously Treated With an Oxaliplatin-Containing Regimen
Status: Enrolling
Updated: 2/28/2017
Clinical Research Facility
mi
from
Corona, CA
Click here to add this to my saved trials
Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
A Multicenter, Single Arm, Open Label Clinical Trial to Evaluate the Safety and Health-Related Quality of Life of Aflibercept in Patients With Metastatic Colorectal Cancer (mCRC) Previously Treated With an Oxaliplatin-Containing Regimen
Status: Enrolling
Updated:  2/28/2017
Clinical Research Facility
mi
from
Fountain Valley, CA
Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
A Multicenter, Single Arm, Open Label Clinical Trial to Evaluate the Safety and Health-Related Quality of Life of Aflibercept in Patients With Metastatic Colorectal Cancer (mCRC) Previously Treated With an Oxaliplatin-Containing Regimen
Status: Enrolling
Updated: 2/28/2017
Clinical Research Facility
mi
from
Fountain Valley, CA
Click here to add this to my saved trials
Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
A Multicenter, Single Arm, Open Label Clinical Trial to Evaluate the Safety and Health-Related Quality of Life of Aflibercept in Patients With Metastatic Colorectal Cancer (mCRC) Previously Treated With an Oxaliplatin-Containing Regimen
Status: Enrolling
Updated:  2/28/2017
Clinical Research Facility
mi
from
Riverside, CA
Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
A Multicenter, Single Arm, Open Label Clinical Trial to Evaluate the Safety and Health-Related Quality of Life of Aflibercept in Patients With Metastatic Colorectal Cancer (mCRC) Previously Treated With an Oxaliplatin-Containing Regimen
Status: Enrolling
Updated: 2/28/2017
Clinical Research Facility
mi
from
Riverside, CA
Click here to add this to my saved trials
Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
A Multicenter, Single Arm, Open Label Clinical Trial to Evaluate the Safety and Health-Related Quality of Life of Aflibercept in Patients With Metastatic Colorectal Cancer (mCRC) Previously Treated With an Oxaliplatin-Containing Regimen
Status: Enrolling
Updated:  2/28/2017
Clinical Research Facility
mi
from
Indianapolis, IN
Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
A Multicenter, Single Arm, Open Label Clinical Trial to Evaluate the Safety and Health-Related Quality of Life of Aflibercept in Patients With Metastatic Colorectal Cancer (mCRC) Previously Treated With an Oxaliplatin-Containing Regimen
Status: Enrolling
Updated: 2/28/2017
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
A Multicenter, Single Arm, Open Label Clinical Trial to Evaluate the Safety and Health-Related Quality of Life of Aflibercept in Patients With Metastatic Colorectal Cancer (mCRC) Previously Treated With an Oxaliplatin-Containing Regimen
Status: Enrolling
Updated:  2/28/2017
Clinical Research Facility
mi
from
Metairie, LA
Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
A Multicenter, Single Arm, Open Label Clinical Trial to Evaluate the Safety and Health-Related Quality of Life of Aflibercept in Patients With Metastatic Colorectal Cancer (mCRC) Previously Treated With an Oxaliplatin-Containing Regimen
Status: Enrolling
Updated: 2/28/2017
Clinical Research Facility
mi
from
Metairie, LA
Click here to add this to my saved trials
Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
A Multicenter, Single Arm, Open Label Clinical Trial to Evaluate the Safety and Health-Related Quality of Life of Aflibercept in Patients With Metastatic Colorectal Cancer (mCRC) Previously Treated With an Oxaliplatin-Containing Regimen
Status: Enrolling
Updated:  2/28/2017
Clinical Research Facility
mi
from
Rockville, MD
Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
A Multicenter, Single Arm, Open Label Clinical Trial to Evaluate the Safety and Health-Related Quality of Life of Aflibercept in Patients With Metastatic Colorectal Cancer (mCRC) Previously Treated With an Oxaliplatin-Containing Regimen
Status: Enrolling
Updated: 2/28/2017
Clinical Research Facility
mi
from
Rockville, MD
Click here to add this to my saved trials
Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
A Multicenter, Single Arm, Open Label Clinical Trial to Evaluate the Safety and Health-Related Quality of Life of Aflibercept in Patients With Metastatic Colorectal Cancer (mCRC) Previously Treated With an Oxaliplatin-Containing Regimen
Status: Enrolling
Updated:  2/28/2017
Clinical Research Facility
mi
from
Howell, NJ
Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
A Multicenter, Single Arm, Open Label Clinical Trial to Evaluate the Safety and Health-Related Quality of Life of Aflibercept in Patients With Metastatic Colorectal Cancer (mCRC) Previously Treated With an Oxaliplatin-Containing Regimen
Status: Enrolling
Updated: 2/28/2017
Clinical Research Facility
mi
from
Howell, NJ
Click here to add this to my saved trials
Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
A Multicenter, Single Arm, Open Label Clinical Trial to Evaluate the Safety and Health-Related Quality of Life of Aflibercept in Patients With Metastatic Colorectal Cancer (mCRC) Previously Treated With an Oxaliplatin-Containing Regimen
Status: Enrolling
Updated:  2/28/2017
Clinical Research Facility
mi
from
Albuquerque, NM
Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
A Multicenter, Single Arm, Open Label Clinical Trial to Evaluate the Safety and Health-Related Quality of Life of Aflibercept in Patients With Metastatic Colorectal Cancer (mCRC) Previously Treated With an Oxaliplatin-Containing Regimen
Status: Enrolling
Updated: 2/28/2017
Clinical Research Facility
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
A Multicenter, Single Arm, Open Label Clinical Trial to Evaluate the Safety and Health-Related Quality of Life of Aflibercept in Patients With Metastatic Colorectal Cancer (mCRC) Previously Treated With an Oxaliplatin-Containing Regimen
Status: Enrolling
Updated:  2/28/2017
Clinical Research Facility
mi
from
Farmington, NM
Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
A Multicenter, Single Arm, Open Label Clinical Trial to Evaluate the Safety and Health-Related Quality of Life of Aflibercept in Patients With Metastatic Colorectal Cancer (mCRC) Previously Treated With an Oxaliplatin-Containing Regimen
Status: Enrolling
Updated: 2/28/2017
Clinical Research Facility
mi
from
Farmington, NM
Click here to add this to my saved trials
Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
A Multicenter, Single Arm, Open Label Clinical Trial to Evaluate the Safety and Health-Related Quality of Life of Aflibercept in Patients With Metastatic Colorectal Cancer (mCRC) Previously Treated With an Oxaliplatin-Containing Regimen
Status: Enrolling
Updated:  2/28/2017
Clinical Research Facility
mi
from
Lake Success, NY
Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
A Multicenter, Single Arm, Open Label Clinical Trial to Evaluate the Safety and Health-Related Quality of Life of Aflibercept in Patients With Metastatic Colorectal Cancer (mCRC) Previously Treated With an Oxaliplatin-Containing Regimen
Status: Enrolling
Updated: 2/28/2017
Clinical Research Facility
mi
from
Lake Success, NY
Click here to add this to my saved trials
Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
A Multicenter, Single Arm, Open Label Clinical Trial to Evaluate the Safety and Health-Related Quality of Life of Aflibercept in Patients With Metastatic Colorectal Cancer (mCRC) Previously Treated With an Oxaliplatin-Containing Regimen
Status: Enrolling
Updated:  2/28/2017
Clinical Research Facility
mi
from
Middletown, OH
Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
A Multicenter, Single Arm, Open Label Clinical Trial to Evaluate the Safety and Health-Related Quality of Life of Aflibercept in Patients With Metastatic Colorectal Cancer (mCRC) Previously Treated With an Oxaliplatin-Containing Regimen
Status: Enrolling
Updated: 2/28/2017
Clinical Research Facility
mi
from
Middletown, OH
Click here to add this to my saved trials
Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
A Multicenter, Single Arm, Open Label Clinical Trial to Evaluate the Safety and Health-Related Quality of Life of Aflibercept in Patients With Metastatic Colorectal Cancer (mCRC) Previously Treated With an Oxaliplatin-Containing Regimen
Status: Enrolling
Updated:  2/28/2017
Investigational Site Number 056010
mi
from
Aalst,
Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
A Multicenter, Single Arm, Open Label Clinical Trial to Evaluate the Safety and Health-Related Quality of Life of Aflibercept in Patients With Metastatic Colorectal Cancer (mCRC) Previously Treated With an Oxaliplatin-Containing Regimen
Status: Enrolling
Updated: 2/28/2017
Investigational Site Number 056010
mi
from
Aalst,
Click here to add this to my saved trials
Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients
Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients
Status: Enrolling
Updated:  3/9/2017
DCSNO Carrollton Medical Center
mi
from
New Orleans, LA
Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients
Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients
Status: Enrolling
Updated: 3/9/2017
DCSNO Carrollton Medical Center
mi
from
New Orleans, LA
Click here to add this to my saved trials
Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients
Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients
Status: Enrolling
Updated:  3/9/2017
DCSNO St Cecelia Medical Center
mi
from
New Orleans, LA
Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients
Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients
Status: Enrolling
Updated: 3/9/2017
DCSNO St Cecelia Medical Center
mi
from
New Orleans, LA
Click here to add this to my saved trials
Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients
Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients
Status: Enrolling
Updated:  3/9/2017
EXCELth - Ida Hymel Community Health Center
mi
from
New Orleans, LA
Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients
Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients
Status: Enrolling
Updated: 3/9/2017
EXCELth - Ida Hymel Community Health Center
mi
from
New Orleans, LA
Click here to add this to my saved trials
Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients
Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients
Status: Enrolling
Updated:  3/9/2017
Tulane Communty Health Center at Covenant House
mi
from
New Orleans, LA
Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients
Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients
Status: Enrolling
Updated: 3/9/2017
Tulane Communty Health Center at Covenant House
mi
from
New Orleans, LA
Click here to add this to my saved trials
Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients
Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients
Status: Enrolling
Updated:  3/9/2017
Tulane Faculty Practice
mi
from
New Orleans, LA
Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients
Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients
Status: Enrolling
Updated: 3/9/2017
Tulane Faculty Practice
mi
from
New Orleans, LA
Click here to add this to my saved trials
Study of CM-24 (MK-6018) Alone and In Combination With Pembrolizumab (MK-3475) in Participants With Selected Advanced or Recurrent Malignancies (MK-6018-001)
A Phase 1, Open-Label, Multicenter, Multi-Dose Escalation Study of CM-24 (MK-6018) as Monotherapy and In Combination With Pembrolizumab (MK-3475) in Subjects With Selected Advanced or Recurrent Malignancies
Status: Enrolling
Updated:  3/15/2017
Clinical Research Facility
mi
from
Los Angeles, CA
Study of CM-24 (MK-6018) Alone and In Combination With Pembrolizumab (MK-3475) in Participants With Selected Advanced or Recurrent Malignancies (MK-6018-001)
A Phase 1, Open-Label, Multicenter, Multi-Dose Escalation Study of CM-24 (MK-6018) as Monotherapy and In Combination With Pembrolizumab (MK-3475) in Subjects With Selected Advanced or Recurrent Malignancies
Status: Enrolling
Updated: 3/15/2017
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study of CM-24 (MK-6018) Alone and In Combination With Pembrolizumab (MK-3475) in Participants With Selected Advanced or Recurrent Malignancies (MK-6018-001)
A Phase 1, Open-Label, Multicenter, Multi-Dose Escalation Study of CM-24 (MK-6018) as Monotherapy and In Combination With Pembrolizumab (MK-3475) in Subjects With Selected Advanced or Recurrent Malignancies
Status: Enrolling
Updated:  3/15/2017
Clinical Research Facility
mi
from
New Haven, CT
Study of CM-24 (MK-6018) Alone and In Combination With Pembrolizumab (MK-3475) in Participants With Selected Advanced or Recurrent Malignancies (MK-6018-001)
A Phase 1, Open-Label, Multicenter, Multi-Dose Escalation Study of CM-24 (MK-6018) as Monotherapy and In Combination With Pembrolizumab (MK-3475) in Subjects With Selected Advanced or Recurrent Malignancies
Status: Enrolling
Updated: 3/15/2017
Clinical Research Facility
mi
from
New Haven, CT
Click here to add this to my saved trials
Study of CM-24 (MK-6018) Alone and In Combination With Pembrolizumab (MK-3475) in Participants With Selected Advanced or Recurrent Malignancies (MK-6018-001)
A Phase 1, Open-Label, Multicenter, Multi-Dose Escalation Study of CM-24 (MK-6018) as Monotherapy and In Combination With Pembrolizumab (MK-3475) in Subjects With Selected Advanced or Recurrent Malignancies
Status: Enrolling
Updated:  3/15/2017
Merck Sharp & Dohme Co. Ltd.
mi
from
Hod Hasharon,
Study of CM-24 (MK-6018) Alone and In Combination With Pembrolizumab (MK-3475) in Participants With Selected Advanced or Recurrent Malignancies (MK-6018-001)
A Phase 1, Open-Label, Multicenter, Multi-Dose Escalation Study of CM-24 (MK-6018) as Monotherapy and In Combination With Pembrolizumab (MK-3475) in Subjects With Selected Advanced or Recurrent Malignancies
Status: Enrolling
Updated: 3/15/2017
Merck Sharp & Dohme Co. Ltd.
mi
from
Hod Hasharon,
Click here to add this to my saved trials
Japanese National Computed Tomographic (CT) Colonography Trial
Evaluation of Accuracy of Computed Tomographic Colonography (CTC) in the Diagnosis of Colorectal Tumors by Gastroenterologists and Radiologists With Computer-aided Detection (CAD): A Multicenter Study
Status: Enrolling
Updated:  3/16/2017
Japanese CTC Society, 3D imaging Laboratory, Massachusetts General Hospital
mi
from
Boston, MA
Japanese National Computed Tomographic (CT) Colonography Trial
Evaluation of Accuracy of Computed Tomographic Colonography (CTC) in the Diagnosis of Colorectal Tumors by Gastroenterologists and Radiologists With Computer-aided Detection (CAD): A Multicenter Study
Status: Enrolling
Updated: 3/16/2017
Japanese CTC Society, 3D imaging Laboratory, Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Japanese National Computed Tomographic (CT) Colonography Trial
Evaluation of Accuracy of Computed Tomographic Colonography (CTC) in the Diagnosis of Colorectal Tumors by Gastroenterologists and Radiologists With Computer-aided Detection (CAD): A Multicenter Study
Status: Enrolling
Updated:  3/16/2017
Otarukyokai Hospital
mi
from
Otaru,
Japanese National Computed Tomographic (CT) Colonography Trial
Evaluation of Accuracy of Computed Tomographic Colonography (CTC) in the Diagnosis of Colorectal Tumors by Gastroenterologists and Radiologists With Computer-aided Detection (CAD): A Multicenter Study
Status: Enrolling
Updated: 3/16/2017
Otarukyokai Hospital
mi
from
Otaru,
Click here to add this to my saved trials
Risk Stratification to Promote Effective Shared Decision-Making for Colorectal Cancer Screening
Impact of Risk Stratification on Shared Decision-Making for Colorectal Cancer Screening
Status: Enrolling
Updated:  3/20/2017
Boston Med Ctr
mi
from
Boston, MA
Risk Stratification to Promote Effective Shared Decision-Making for Colorectal Cancer Screening
Impact of Risk Stratification on Shared Decision-Making for Colorectal Cancer Screening
Status: Enrolling
Updated: 3/20/2017
Boston Med Ctr
mi
from
Boston, MA
Click here to add this to my saved trials
Imaging of Radiolabeled White Blood Cells in Patients With Non-Hodgkin's Lymphoma
In Vivo Imaging of Effector Cells in Anti-Lymphoma Therapy
Status: Enrolling
Updated:  3/21/2017
Holden Comprehensive Cancer Center at University of Iowa
mi
from
Iowa City, IA
Imaging of Radiolabeled White Blood Cells in Patients With Non-Hodgkin's Lymphoma
In Vivo Imaging of Effector Cells in Anti-Lymphoma Therapy
Status: Enrolling
Updated: 3/21/2017
Holden Comprehensive Cancer Center at University of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials
Imaging of Radiolabeled White Blood Cells in Patients With Non-Hodgkin's Lymphoma
In Vivo Imaging of Effector Cells in Anti-Lymphoma Therapy
Status: Enrolling
Updated:  3/21/2017
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Imaging of Radiolabeled White Blood Cells in Patients With Non-Hodgkin's Lymphoma
In Vivo Imaging of Effector Cells in Anti-Lymphoma Therapy
Status: Enrolling
Updated: 3/21/2017
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Click here to add this to my saved trials
Microbiome Test for the Detection of Colorectal Polyps and Cancer
Metabiomics Neoplasia Clinical Research Study
Status: Enrolling
Updated:  3/27/2017
DC Endoscopy Center
mi
from
Washington,
Microbiome Test for the Detection of Colorectal Polyps and Cancer
Metabiomics Neoplasia Clinical Research Study
Status: Enrolling
Updated: 3/27/2017
DC Endoscopy Center
mi
from
Washington,
Click here to add this to my saved trials
Microbiome Test for the Detection of Colorectal Polyps and Cancer
Metabiomics Neoplasia Clinical Research Study
Status: Enrolling
Updated:  3/27/2017
Chevy Chase Endoscopy Center
mi
from
Chevy Chase, MD
Microbiome Test for the Detection of Colorectal Polyps and Cancer
Metabiomics Neoplasia Clinical Research Study
Status: Enrolling
Updated: 3/27/2017
Chevy Chase Endoscopy Center
mi
from
Chevy Chase, MD
Click here to add this to my saved trials
Study of Effects of L-Arginine in Colitis and Colon Cancer
Immunomodulary Effects of Arginine Supplementation in Colitis and Colon Cancer
Status: Enrolling
Updated:  3/30/2017
Vanderbilt Hospital
mi
from
Nashville, TN
Study of Effects of L-Arginine in Colitis and Colon Cancer
Immunomodulary Effects of Arginine Supplementation in Colitis and Colon Cancer
Status: Enrolling
Updated: 3/30/2017
Vanderbilt Hospital
mi
from
Nashville, TN
Click here to add this to my saved trials